The Resource for your Nonhuman Primate Research

We support innovation, reproducibility, and translation of preclinical research with high-quality biological development. We offer primate antibodies and recombinant proteins for pre-clinical NHP studies, NHP-specific reagents for in vitro assays, and have an industry wide antibody reactivity database for NHP species.

Our Products

Reactivity Database

Partner With Us

Recent Publications Using Our Reagents...

View All

 

NHPRR Product Catalog

 

Assay Reagent Catalog

 

New World Monkey Reagents

 

NHPRR Therapeutics Catalog

 

NHPRR News and Announcements

Follow the latest news on NHPRR's LinkedIn account and News Archives

 

 

2025 January 01

CD154 blockade effectively controls antibody-mediated rejection in highly sensitized nonhuman primate kidney transplant recipients.

Anwar, Imran J DeLaura, Isabel Ladowski, Joseph M Schilirò, Davide Gao, Qimeng Manook, Miriam Yoon, Janghoon Belloni, Rafaela Park, Angela Schuster, Daniel J Song, Mingqing Lin, Lin Farris, Alton B Magnani, Diogo Williams, Kyha Kwun, Jean Knechtle, Stuart J

Sci Transl Med

Anti-CD154 [5C8H1]

2024 December 20

Humoral correlates of protection against Mycobacterium tuberculosis following intravenous BCG vaccination in rhesus macaques.

Irvine, Edward B Darrah, Patricia A Wang, Shu Wang, Chuangqi McNamara, Ryan P Roederer, Mario Seder, Robert A Lauffenburger, Douglas A Flynn, JoAnne L Fortune, Sarah M Alter, Galit

iScience

Anti-rhesus IgG1 [ena]-HRP Anti-rhesus IgA [9B9]

2024 December 10

Induction of Tier 2 HIV-Neutralizing IgA Antibodies in Rhesus Macaques Vaccinated with BG505.664 SOSIP.

Smith, Justin C Arunachalam, Prabhu S Legere, Traci H Cavacini, Lisa A Hunter, Eric Pulendran, Bali Amara, Rama R Kozlowski, Pamela A

Vaccines (Basel)

Anti-rhesus J chain [CA1L_33e1_A1a3] Anti-rhesus J chain [CA1L_33e1_A1a3]-biotin Reference rhesus dimeric IgA [b12rA1d] Reference rhesus monomeric IgA [b12rA1m]

News & Updates:

View All

2024 Aug 23

mAbsolve Parnership for Fc-silenced STR Antibodies

Today, we celebrate a milestone—partnering with mAbsolve to incorporate ‘STR’ mutations into our antibodies. This ensures targeted action without unintended immune responses, boosting rigor, effectiveness, and safety. By decreasing Fc-mediated interference (hello Fc-block!) and enhancing the signal-to-noise ratio, STR-enhanced antibodies will produce more robust and reproducible scientific findings. Expect many STR-enhanced antibodies soon!

READ MORE

2024 Apr 09

For your Acknowledgements section

Reagents used in these studies were provided by the NIH Nonhuman Primate Reagent Resource (P40 OD028116, U24 AI126683).

2024 Apr 11

NHPRR Linkedin

Follow our newest publications, products, and messages on LinkedIn!

READ MORE

2024 Apr 09

RRID Citation on Materials and Methods

For your Materials & Methods section: The rhesus recombinant Anti-CD8 beta [CD8b255R1] monoclonal antibody was engineered and produced by the Nonhuman Primate Reagent Resource (NIH Nonhuman Primate Reagent Resource Cat# PR-2557, RRID:AB_2716321)

Contribute to the Resource

Help Us By:

Sharing Your Data: Our community-based reactivity database is built by users like you. Share your results!

Requesting a Reagent: We develop NHP-specific antibodies based on investigator-initiated requests, including: recombinant proteins for cell depletion, receptor activation, cytokine neutralization, co-stimulatory blockade, immunosuppression.

Licensing Our Reagents: Interested in using our antibodies on your assays? Reach us!

Sharing Your Publication: If you’ve recently published a study using an NHPRR reagent, add it to the publication database.

The Nonhuman Primate Reagent Resource (NHPRR) is a nonprofit laboratory established in 1999, and supported by the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), and Office of Research Infrastructure Programs (ORIP).

Copyright © 2004-2025